Skip to content
Clinical Research Made Simple

Clinical Research Made Simple

Trusted Resource for Clinical Trials, Protocols & Progress

Tag: ICH E5 ethnic factors

ICH Guidelines for Multiregional Clinical Trials: Understanding E5, E17, and Global Harmonization

Posted on May 8, 2025 digi By digi

ICH Guidelines for Multiregional Clinical Trials: Understanding E5, E17, and Global Harmonization Mastering Multiregional Clinical Trials with ICH E5 and E17 Guidelines Conducting clinical trials across multiple regions has become increasingly essential for pharmaceutical companies aiming for simultaneous global drug approvals. To address the complexity of such trials, the International Council for Harmonisation (ICH) introduced…

Read More “ICH Guidelines for Multiregional Clinical Trials: Understanding E5, E17, and Global Harmonization” »

ICH Guidelines, Regulatory Guidelines

Quick Guide

  • Clinical Trial Phases
    • Preclinical Studies
    • Phase 0 (Microdosing Studies)
    • Phase 1 (Safety and Dosage)
    • Phase 2 (Efficacy and Side Effects)
    • Phase 3 (Confirmation and Monitoring)
    • Phase 4 (Post-Marketing Surveillance)
  • Regulatory Guidelines
    • U.S. FDA Regulations
    • CDSCO (India) Guidelines
    • EMA (European Medicines Agency) Guidelines
    • PMDA (Japan) Guidelines
    • MHRA (UK) Guidelines
    • TGA (Australia) Guidelines
    • Health Canada Guidelines
    • WHO Guidelines
    • ICH Guidelines
    • ASEAN Guidelines
  • Clinical Trial Design and Protocol Development
    • Randomized Controlled Trials (RCTs)
    • Adaptive Trial Designs
    • Crossover Trials
    • Parallel Group Designs
    • Factorial Designs
    • Cluster Randomized Trials
    • Single-Arm Trials
    • Open-Label Studies
    • Blinded Studies (Single, Double, Triple)
    • Non-Inferiority and Equivalence Trials
    • Randomization Techniques in Crossover Trials
  • Good Clinical Practice (GCP) and Compliance
    • GCP Training Programs
    • ICH-GCP Compliance
    • GCP Violations and Audit Responses
    • Monitoring Plans
    • Investigator Responsibilities
    • Sponsor Responsibilities
    • Ethics Committee Roles

Menu

Recent Posts

  • Incorporating PROs and QoL Data in Phase 4 Clinical Trials
  • Evaluating Drug Efficacy Using Parallel Methodology – Clinical Trial Design and Protocol Development
  • Phase 1 Studies for Inhaled Therapies: PK, PD, and Device Considerations
  • How to Prepare for GCP Inspections During Ongoing Phase 3 Trials: Compliance, Readiness, and Best Practices
  • Blinding and Randomization in Parallel Designs – Clinical Trial Design and Protocol Development

Copyright © 2025 Clinical Research Made Simple.

Powered by PressBook WordPress theme